Sun.Nov 26, 2023

article thumbnail

Five Things To Know About Beta-Lactam Therapeutic Drug Monitoring (TDM)

IDStewardship

In this article 3 clinical pharmacists provide insights, pulling from their advanced experience with beta-lactam therapeutic drug monitoring (TDM). Photo pending Authored By : Kathryn DeSear, PharmD; Barbara Santevecchi, PharmD; Veena Venugopalan, PharmD; Lisa Vuong PharmD Article Posted 28 November 2023 Beta-lactam antibiotics are time-dependent antibiotics, which means that by increasing the time the free drug concentration remains above the minimum inhibitory concentration (% f T>MIC) of

article thumbnail

‘They thought I had cancer’: painkiller banned in UK linked to Britons’ deaths in Spain

The Guardian - Pharmaceutical Industry

Patients’ group says reactions to metamizole can cause sepsis and organ failure – and British and Irish people are at higher risk A patients group representing several British victims has launched legal action against the Spanish government over claims it failed to safeguard people against the potentially fatal side effects of one of the country’s most popular painkillers, involved in a series of serious illnesses and deaths.

143
143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: With new trial data, a blockbuster therapy from Sanofi, Regeneron could find an even bigger market

STAT

LONDON — The inflammation-targeting therapy Dupixent succeeded in a Phase 3 trial in patients with the chronic lung disease COPD, its developers said Monday, results that could propel the blockbuster medicine into a massive new market. Dupixent, which is jointly developed by Sanofi and Regeneron Pharmaceuticals, has already racked up approvals for several indications, including asthma, atopic dermatitis, and eosinophilic esophagitis.

125
125
article thumbnail

National Pharmacy Commission Bill, 2023 : A Critical Review

Pharma Tutor

National Pharmacy Commission Bill, 2023 : A Critical Review admin Mon, 11/27/2023 - 12:22 ABOUT AUTHOR Dr. R. S. Thakur Former Secretary, Pharmacy Council of India. Email : drramsthakur@gmail.

85
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Startup Forum secures $5.3M to build out digital peer support group marketplace

Fierce Healthcare

Peer support groups can help people navigate major life challenges and get needed support to manage grief, address loneliness or even guide them through a career change. | New startup Forum offers a two-sided virtual peer support group marketplace to help individuals find the support they need. The marketplace has a rapidly expanding list of groups that cover topics like grief, loneliness, chronic conditions, substance use recovery and caregiving.

73
article thumbnail

Stimulants and Elderly Patients – Case Study

Med Ed 101

In this case, I outline a unique situation involving stimulants and elderly patients. I outline some of the potential complications and contributions to the prescribing cascade. A 76-year-old female resides in an assisted living. She has a history of ADHD, anxiety, insomnia, diabetes, hypertension, back pain, and GERD. Her current medication list includes the following: […] The post Stimulants and Elderly Patients – Case Study appeared first on Med Ed 101.